COVID 19 update: Mumbai reports 31 deaths in 24 hrs, highest since October; 10,030 test positive for coronavirus
The growth rate of COVID-19 has increased to 1.79 percent, while the case doubling rate has dropped to 38 days, BMC said
Mumbai: Mumbai reported 10,030 new COVID- 19 cases on Tuesday, the second highest daily count so far while 31 patients succumbed to the infection, the most in a day since October-end, the city civic body said.
The new cases took the cumulative tally to 4,72,332 while the death toll jumped to 11,828, according to the Brihanmumbai Municipal Corporation (BMC) data.
At 10,030 new cases, Mumbai registered its second highest daily count after a record 11,163 infections were reported on 4 April. The 31 fresh deaths were the highest in a 24-hour period since October-end, the data showed.
Also, 7,019 more people were discharged from hospitals, taking the number of recovered patients to 3,82,004, the civic body said. According to the BMC, the number of active COVID-19cases increased to 77,495.
The data pointed out that 47,922 more COVID-19 tests were carried out in Mumbai, pushing the number of samples examined so far to 43,53,975. The COVID-19 recovery rate in Mumbai has gone down to 81 percent, according to the BMC.
The growth rate of COVID-19 has increased to 1.79 percent, while the case doubling rate has dropped to 38 days, it said. The civic body said the city currently has 73 active containment zones in slums and 'chawls' (old tenements) and 740 sealed buildings.
10 more people charged in $250M federal food program fraud
A total of 60 people have now been charged in the conspiracy, in which authorities say a group of people took advantage of rules that were relaxed during the COVID-19 pandemic and falsely claimed they were providing food to children.
On this day: Important events that happened on 11 March in the past
The World Health Organization (WHO) had declared on 11 March 2020 that the COVID-19 outbreak was a pandemic
COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.